BACKGROUND: Based on the known inflammatory role of interleukins (IL), we evaluated IL-1beta and IL-6 expressions and their association with the severity of traumatic brain injury (TBI; Glasgow Coma Scale [GCS]) and the outcome (Glasgow Outcome Score [GOS]) recorded in a paediatric population. DESIGN: The design was a perspective observational clinical study carried out in the paediatric intensive care unit of the University Hospital. METHODS: We measured the IL-1beta and IL-6 levels in 14 children with severe TBI (patients) and in 12 children with obstructive hydrocephalus (control group). Cerebrospinal fluid (CSF) and plasma samples were collected 2 h (T1) and 24 h (T2) after TBI. Interleukins were assayed using the immunoenzymatic method. RESULTS: The IL-1beta mean level was significantly lower than the IL-6 mean level both in the CSF and plasma of TBI children. In the CSF, the IL-1beta level increased from 55.71+/-72.79 pg/ml at T1 to 106.10+/-142.12 pg/ml at T2 and the IL-6 level increased from 405.43+/-280.28 pg/ml at T1 to 631.57+/-385.35 pg/ml at T2; a similar trend was observed in plasma. We found a statistically significant correlation between the increase in CSF and plasma interleukin levels between T1 and T2 and head injury severity (GCS<or=5) as well as poor outcome (GOS<or=3). CONCLUSIONS: The increases in IL-1beta and IL-6 expression were correlated with head injury severity and were indicative of poor clinical outcome, reflecting an endogenous neuroinflammatory response after TBI.
BACKGROUND: Based on the known inflammatory role of interleukins (IL), we evaluated IL-1beta and IL-6 expressions and their association with the severity of traumatic brain injury (TBI; Glasgow Coma Scale [GCS]) and the outcome (Glasgow Outcome Score [GOS]) recorded in a paediatric population. DESIGN: The design was a perspective observational clinical study carried out in the paediatric intensive care unit of the University Hospital. METHODS: We measured the IL-1beta and IL-6 levels in 14 children with severe TBI (patients) and in 12 children with obstructive hydrocephalus (control group). Cerebrospinal fluid (CSF) and plasma samples were collected 2 h (T1) and 24 h (T2) after TBI. Interleukins were assayed using the immunoenzymatic method. RESULTS: The IL-1beta mean level was significantly lower than the IL-6 mean level both in the CSF and plasma of TBI children. In the CSF, the IL-1beta level increased from 55.71+/-72.79 pg/ml at T1 to 106.10+/-142.12 pg/ml at T2 and the IL-6 level increased from 405.43+/-280.28 pg/ml at T1 to 631.57+/-385.35 pg/ml at T2; a similar trend was observed in plasma. We found a statistically significant correlation between the increase in CSF and plasma interleukin levels between T1 and T2 and head injury severity (GCS<or=5) as well as poor outcome (GOS<or=3). CONCLUSIONS: The increases in IL-1beta and IL-6 expression were correlated with head injury severity and were indicative of poor clinical outcome, reflecting an endogenous neuroinflammatory response after TBI.
Authors: Ido Yatsiv; Maria C Morganti-Kossmann; Daniel Perez; Charles A Dinarello; Daniela Novick; Menachem Rubinstein; Viviane I Otto; Mario Rancan; Thomas Kossmann; Claudio A Redaelli; Otmar Trentz; Esther Shohami; Philip F Stahel Journal: J Cereb Blood Flow Metab Date: 2002-08 Impact factor: 6.200
Authors: S C Donnelly; R M Strieter; S L Kunkel; A Walz; C R Robertson; D C Carter; I S Grant; A J Pollok; C Haslett Journal: Lancet Date: 1993-03-13 Impact factor: 79.321
Authors: Abhijit V Lele; Bhunyawee Alunpipatthanachai; Qian Qiu; Crystalyn Clark-Bell; Arraya Watanitanon; Anne Moore; Randall M Chesnut; William Armstead; Monica S Vavilala Journal: Dev Neurosci Date: 2019-09-25 Impact factor: 2.984
Authors: Dennis W Simon; Mandy J McGeachy; Hülya Bayır; Robert S B Clark; David J Loane; Patrick M Kochanek Journal: Nat Rev Neurol Date: 2017-02-10 Impact factor: 42.937
Authors: Jessica S Wallisch; Dennis W Simon; Hülya Bayır; Michael J Bell; Patrick M Kochanek; Robert S B Clark Journal: Neurocrit Care Date: 2017-08 Impact factor: 3.210
Authors: Steven L Shein; David K Shellington; Jennifer L Exo; Travis C Jackson; Stephen R Wisniewski; Edwin K Jackson; Vincent A Vagni; Hülya Bayır; Robert S B Clark; C Edward Dixon; Keri L Janesko-Feldman; Patrick M Kochanek Journal: J Neurotrauma Date: 2014-08-15 Impact factor: 5.269
Authors: Georgene W Hergenroeder; Anthony N Moore; J Philip McCoy; Leigh Samsel; Norman H Ward; Guy L Clifton; Pramod K Dash Journal: J Neuroinflammation Date: 2010-03-11 Impact factor: 8.322
Authors: Michael Frink; Martijn van Griensven; Philipp Kobbe; Thomas Brin; Christian Zeckey; Bernhard Vaske; Christian Krettek; Frank Hildebrand Journal: Scand J Trauma Resusc Emerg Med Date: 2009-09-27 Impact factor: 2.953